Patent details

300920 Product Name: inotuzumab ozogamicine

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300920
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1504035
Status:
SPC in force
Application number:
300920
Procedural language:
Dutch
First Applicant Residence Country:
Belgium (BE)

Marketing Authorization

Marketing Authorization Number:
EU/1/17/1200
Marketing Authorization Type:
EEA
Marketing Authorization Date:
03/07/2017
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
21/12/2017
First Marketing Authorization date:
03/07/2017
Grant date:
15/04/2021
Activation date:
02/05/2023
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
28/12/2017
SPC/SPC Extension Expiration Date:
01/05/2028
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
21/12/2017
 
 

 

Name:
UCB Pharma, S.A.
Address:
Allée de La Recherche 60, 1070 BRUSSELS, Belgium (BE)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
28/07/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
21/12/2017
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
28/07/2025

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
18/23
Publication date:
03/05/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
16/21
Publication date:
21/04/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
02/18
Publication date:
03/01/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/05/2026
Annual Fee Number:
24
Annual Fee Amount:
2200 Euro
Last Annual Payment Date:
15/04/2025
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
2000 Euro
Payer:
Arnold & Siedsma BV
Filing date Document type Document Description Number of pages File Type
15/04/2021 Certificate Certificate 1 PDF /0/4/1/8/2/0800228140/docs/300920_7_spcmedcertificate20210415113306887.pdf
15/04/2021 Outgoing Correspondence Decision grant 1 PDF /0/4/1/8/2/0800228140/docs/300920_14_406393l504a.pdf
15/01/2019 Outgoing Correspondence Outgoing Letter 1 PDF /0/4/1/8/2/0800228140/docs/300920_11_outgoingcorrespondence20190116025757018.pdf
08/01/2019 Incoming Correspondence Paper Accompanying letter incoming document 3 PDF /0/4/1/8/2/0800228140/docs/300920_15_incomingcorrespondencepaper20190109115002097.pdf
04/01/2019 Incoming Correspondence Paper Mail 12 PDF /0/4/1/8/2/0800228140/docs/300920_13_incomingcorrespondencepaper20190111095741866.pdf
18/12/2018 Examination Internal New 1 PDF /0/4/1/8/2/0800228140/docs/300920_18_examination20181218132008764.pdf
26/10/2018 Incoming Correspondence Paper Mail 1 PDF /0/4/1/8/2/0800228140/docs/300920_8_incomingcorrespondencepaper20200511022050471.pdf
02/08/2018 Examination Internal New 3 PDF /0/4/1/8/2/0800228140/docs/300920_0_examination20180802133711370.pdf
02/08/2018 Outgoing Correspondence Outgoing Letter 3 PDF /0/4/1/8/2/0800228140/docs/300920_2_outgoingcorrespondence20180810113904288.pdf
02/08/2018 Examination Internal New 28 PDF /0/4/1/8/2/0800228140/docs/300920_6_examination20180802133649756.pdf
02/08/2018 Examination Internal New 133 PDF /0/4/1/8/2/0800228140/docs/300920_16_examination20180802133657338.pdf
28/12/2017 Outgoing Correspondence Confirmation receipt request 1 PDF /0/4/1/8/2/0800228140/docs/300920_10_184026l174.pdf
22/12/2017 Incoming Correspondence Paper Accompanying letter incoming document 1 PDF /0/4/1/8/2/0800228140/docs/300920_1_incomingcorrespondencepaper20171228012223203.pdf
22/12/2017 Application Form First filed application form 3 PDF /0/4/1/8/2/0800228140/docs/300920_3_applicationform20171228012223032.pdf
22/12/2017 SPC Documents Annex SPC 59 PDF /0/4/1/8/2/0800228140/docs/300920_4_supplprotectioncertificate20200511011445913.pdf
22/12/2017 SPC Documents Annex SPC 59 PDF /0/4/1/8/2/0800228140/docs/300920_5_supplprotectioncertificate20200511012103718.pdf
22/12/2017 SPC Documents Annex SPC 3 PDF /0/4/1/8/2/0800228140/docs/300920_9_supplprotectioncertificate20171228012223590.pdf
22/12/2017 SPC Documents Annex SPC 2 PDF /0/4/1/8/2/0800228140/docs/300920_12_supplprotectioncertificate20200511011724467.pdf
22/12/2017 SPC Documents Annex SPC 17 PDF /0/4/1/8/2/0800228140/docs/300920_17_supplprotectioncertificate20171228012223691.pdf
22/12/2017 SPC Documents Summary of the characteristics of the product 24 PDF /0/4/1/8/2/0800228140/docs/300920_19_supplprotectioncertificate20171228012223496.pdf
22/12/2017 SPC Documents Marketing Authorization SPC 3 PDF /0/4/1/8/2/0800228140/docs/300920_20_supplprotectioncertificate20171228012223393.pdf